1. Background {#sec98253}
=============

Thalassemia, which is an inherited disorder, is associated with anemia caused by impaired synthesis of globin chain and has a range of complications such as extra medullary hematopoiesis, cardiac failure, arrhythmia, leg ulcer and gall stones ([@A24959R1]-[@A24959R3]). Cardiac failure, secondary to iron over-load, remains the essential cause of mortality in these patients ([@A24959R4], [@A24959R5]). Early diagnosis and precise measurement of myocardial iron deposition would allow better treatment and reduction of cardiac mortality. The principal methods of iron loading measurement are assessment of Liver Iron Concentration (LIC) and serum ferritin ([@A24959R6], [@A24959R7]). Also, non-invasing modalities are increasingly used as an alternative to biopsy and ferritin level assessment, although T2\* Magnetic Resonance Imaging (MRI) is currently the gold standard approach ([@A24959R8], [@A24959R9]). However, T2\* MRI is expensive, not widely available, and its interpretation needs an expert radiologist. The current study aimed to investigate the correlation of serum ferritin levels with LIC, T2\* MRI of heart and liver inpatients with thalassemia.

2. Objectives {#sec98254}
=============

The current study aimed to detect whether the serum ferritin levels could be considered a reliable alternative test or not, also to evaluate cardiac function by echocardiography and investigate the association of systolic ejection fraction with iron over-load.

3. Patients and Methods {#sec98256}
=======================

In the current cross sectional study, 90 patients with Thalassemia Major (TM) and Thalassemia Intermedia (TI) participated from January 2013 to January 2014 in Shiraz, Iran. All patients attended the thalassemia clinic located at the referral state hospital, the only referral hospital with 45 beds for such patients, in Southern Iran. Subject selection was based on systematic random sampling method from a sampling frame (about 720 patients with thalassemia) available at this center. List of the patients was reviewed and medical details including the drug and transfusion histories were obtained. Also, patients or their parents signed consent letters. The study was approved in the Medical Ethics Committee of Shiraz University of Medical Sciences (approval code: 3663 date: 92/9/3). The diagnosis of TM and TI in patients was based on complete blood count and hemoglobin electrophoresis tests, and clinical history evaluated by an expert hematologist. Inclusion criteria were patients with TM when the age of the first blood transfusion was less than two years old, and in patients with TI it was above two years old. All patients have been on regular blood transfusion. Patients with any infections, fever, or positive history of viral hepatitis during checking serum ferritin levels as well as overt heart and liver failure were excluded from the study. Finally five patients were excluded. Blood samples were obtained to assess fasting serum ferritin levels (electrofluorescentassay method, mini VIDAS machine, France) at the beginning of the study by calibrated equipments. All of the patients were assessed by T2\* MRI of liver and heart (Zimmence, Germany, Avanta, 1.5 Tesla), echocardiography (GE VIVID 3, U.S.A, probe 3 MHz), and serum ferritin at the beginning of the research. Conventional echocardiography including the measurement of Ejection Fraction (EF) was done for each patient by an expert cardiologist. All radiographic findings were evaluated by one expert radiologist. According to the type of chelator therapy, patients were categorized into five groups: Group1, used only deferroxamine (Desferal, Novartis) 50 mg/kg/day; group 2 used combination therapy with deferiprone 75 mg/kg/day and deferoxamine 50 mg/kg/day, two days a week; group 3, used only deferasirox 20 - 40 mg/kg/day; group 4 used combination of deferasirox and deferroxamine, and group 5 did not receive any treatment. The duration of iron chelation therapy was at least six months before the study. Myocardial and hepaticiron loading and LIC were classified as normal, mild, moderate, and severe according to T2\* MRI of heart and liver ([Table 1](#tbl25317){ref-type="table"}).

3.1. Statistical Analysis {#sec98255}
-------------------------

Data were analyzed by SPSS v. 17. Test of normality was done by Shapiro-Wilk test. Due to small sample size in subgroups exact methods were used (bootstrap and Monte Carlo) to report P values and confidence interval. Serum ferritin levels did not show normal distribution. Descriptive data were presented as mean, standard deviation, median, inter quartile range (IQR), and boxplots. Student t-test or Mann-Whitney test were used to compare quantitative variables between two groups, and Kruskal-Wallis test was used for the comparison among three or more groups of patients. Qualitative variables were compared by Chi-square test. Spearman correlation test was done to find the correlation between serum ferritin levels and values of T2\* MRI and LIC. All tests considered two-sided and P values \< 0.05 were considered statistically significant. Sample size calculation: Considering α = 0.05, power = 90% and correlation between serum ferritin levels and T2\* MRI of liver: r = -0.44 ([@A24959R10]), 49 patients with thalassemia were acceptable. Finally, 90 patients were enrolled for more accuracy, and five patients were excluded from the study.

4. Results {#sec98257}
==========

Patients with thalassemia consisted of 63, and 22 patients with TM, and TI respectively. The demographic and clinical features of patients with thalassemia are presented in [Table 2](#tbl25318){ref-type="table"}. There are no statistically significant differences between the two groups of patients with thalassemia regarding gender, age, Body Mass Index (BMI) or serum ferritin levels (P \> 0.05). Serum ferritin levels showed a statistically significant positive correlation with LIC (rs = 0.718, P \< 0.001), and statistically significant negative correlation with T2\* Heart (rs = -0.329, P = 0.002), and T2 Liver (rs = -0.698, P \< 0.001), in patients with thalassemia ([Table 3](#tbl25319){ref-type="table"}). However, Ejection fraction was not significantly correlated with serum ferritin levels in the patients (P = 0.399). Also, comparison results of serum ferritin levels among the four groups of patients with thalassemia based on T2 MRI heart and liver, and LIC are presented in [Table 4](#tbl25320){ref-type="table"} and [Figures 1](#fig18867){ref-type="fig"}-[3](#fig18868){ref-type="fig"}. Median serum ferritin levels were significantly associated with the values of T2\* heart (P = 0.004) and T2 liver (P \< 0.001), and LIC (P \< 0.001). Abnormal myocardial iron load (T2\* MRI \< 20 ms) was detected in 58% of the patients among whom 36% had severe myocardial iron load (T2\* MRI \< 10 ms).

###### Classification of Hepatic and Cardiac iron Loading and Liver Iron Concentration ^[a](#fn23726){ref-type="table-fn"}^

  Group             Cardiac T2\* MRI   Hepatic T2\* MRI   LIC
  ----------------- ------------------ ------------------ --------
  **1, Normal**     \> 20              \> 6.3             \< 2
  **2, Mild**       14 - 20            2.8 - 6.3          2 - 5
  **3, Moderate**   10 ≤ 14            1.4 - 2.7          5 - 10
  **4, Severe**     \< 10              \< 1.4             \< 10

^a^Abbreviations: LIC, Liver Iron Concentration.

###### Comparison of Demographic and Paraclinical Data Between the Two Groups of Patients With Thalassemia ^[a](#fn23727){ref-type="table-fn"}^

  Group                                 Age, Mean ± SD   Bootstrap 95% CI   BMI, Mean ± SD   Bootstrap 95% CI   Ferritin, Median, IQR   Bootstrap 95% CI   Male/Female
  ------------------------------------- ---------------- ------------------ ---------------- ------------------ ----------------------- ------------------ -------------
  **Thalassemia major (n = 63)**        22.79 ± 7.1      21.06-24.65        21.15 ± 3.5      20.32-21.99        1700, 3428              1312-2970          30/33
  **Thalassemia intermedia (n = 22)**   22.77 ± 6.2      20.24-25.17        21.13 ± 3.2      19.7-22.4          1094, 1119              935-1434           11/11
  **Bootstrap P value**                 0.994                               0.974                               0.085                                      \> 0.9999

^a^Abbreviations: IQR, Interquartile Range; CI, Confidence Interval.

###### Correlation of Serum Ferritin Level With T2\* MRI, liver Iron Concentration and Ejection Fraction in Patients With Thalassemia ^[a](#fn23728){ref-type="table-fn"}^

  Variables                 Values           Boot strap P Value
  ------------------------- ---------------- -----------------------------------------------
  **T2\* MRI Heart**                         0.002 ^[b](#fn23729){ref-type="table-fn"}^
  Correlation coefficient   -0.329           
  Bootstrap 95% CI          -0.532 - 0.122   
  **T2\* MRI Liver**                         
  Correlation coefficient   -0.698           \< 0.001 ^[b](#fn23729){ref-type="table-fn"}^
  Bootstrap 95% CI          -0.804 - 0.545   
  **LIC**                                    \< 0.001 ^[b](#fn23729){ref-type="table-fn"}^
  Correlation coefficient   \+ 0.718         
  Bootstrap 95% CI          0.58 - 0.817     
  **EF**                                     0.399
  Correlation coefficient   +0.093           
  Bootstrap 95% CI          -0.116 - 0.294   

^a^Abbreviations: LIC, liver iron concentration; EF, ejection fraction.

^b^Statistically significant.

###### Comparison of Median of Serum Ferritin Levels Among Different Groups of Thalassemia Patients Based on T2 Heart, T2 Liver, and LIC^[a](#fn23730){ref-type="table-fn"}^

                       Serum Ferritin Median, IQR   Serum Ferritin Bootstrapped 95% CI for Median   Monte Carlo Significant
  -------------------- ---------------------------- ----------------------------------------------- ----------------------------------------------
  **T2 heart**                                                                                      0.004^[b](#fn23731){ref-type="table-fn"}^
  \> 20 (n = 35)       1207, 1049                   809 - 1434                                      
  14-20 (n = 14)       2995,4257                    1403 - 5013                                     
  10 ≤ 14 (n = 18)     1425,3014                    933 - 3232                                      
  \< 10 (n = 18)       4245,4846                    1198 - 5520                                     
  **T2 liver**                                                                                      
  \> 6.3 (n = 35)      1020, 743                    699 - 1259                                      
  2.8 - 6.3 (n = 15)   1168, 1541                   819 - 2319                                      \< 0.001^[b](#fn23731){ref-type="table-fn"}^
  1.4 - 2.7 (n = 30)   3345, 3267                   2086 - 4304                                     
  \< 1.4 (n = 5)       5724, 4251                   5072 - 12491                                    
  **LIC**                                                                                           \< 0.001^[b](#fn23731){ref-type="table-fn"}^
  \< 2 (n = 35)        976, 743                     697 - 1257                                      
  2 ≤ 5 (n = 16)       1225, 1501                   935 - 2319                                      
  5-10 (n = 29)        3397, 3212                   2377 - 4304                                     
  \> 10 (n = 5)        5724, 4251                   5072 - 12491                                    

^a^Abbreviations: LIC, liver iron concentration; IQR, inter quartile range.

^b^Statistically significant.
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5. Discussion {#sec98258}
=============

Cardiac problems such as heart failure and arrhythmias are the main cause of mortality in patients with thalassemia. Although, cardiac complications in patients with thalassemia are multifactorial, they are mainly related to iron loading toxicity ([@A24959R11], [@A24959R12]). The current study focused on whether the serum ferritin levels could be considered as a parameter to detect cardiac and liver iron loading in patients with thalassemia or not. On the other hand, there was a direct relationship between serum ferritin levels and T2\* MRI of heart and liver. The obtained results showed strong correlation between T2\* MRI of heart relaxation times and serum ferritin indicating that serum ferritin can estimate the cardiac iron loading. Other studies found different correlation strengths, ranging from no correlation to moderate correlation ([@A24959R13], [@A24959R14]). Also, a significant correlation between T2\* MRI of liver and serum ferritin levels was observed in the current study. This is in line with the findings of the study by Zamani et al. who reported that serum ferritin is a good parameter to detect hepatic iron loading ([@A24959R15]). In the literature, several studies showed significant relationship between serum ferritin and LIC. The findings of the current study were in accordance with these studies ([@A24959R16], [@A24959R17]). The current study did not find any statistically significant relationship between the ejection fraction and serum ferritin levels to predict the complications of iron loading. Butsome reports such as those of Montazare et al. and Bosi et al. demonstrated significant correlation between serum ferritin and left ventricular EF ([@A24959R18], [@A24959R19]). The current study was limited due to small sample size in subgroups of patients resolved by performing exact methods of statistical analysis. However, the strong point of the current study was that it found that serum ferritin levels can be used as an alternative method of T2\* MRI in the areas where T2\* MRI is not available. The serum ferritin levels had a significant relationship with liver and heart iron burden. Therefore, it can be used to evaluate iron over-load in areas where access to T2\* MRI is limited.
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